APA
Jinger, S. K., Meena, K. L., Gahlot, G. & Hundekar, P. S. (2024). The Significant Role Biomarkers of Inflammatory Cytokines & Adipokines in Patients with Metabolic syndrome and Type 2 Diabetes Immunopathogenesis. CPD Bulletin Clinical Biochemistry, 9(2), 1-8.
MLA
Jinger, Surendra K., et al. "The Significant Role Biomarkers of Inflammatory Cytokines & Adipokines in Patients with Metabolic syndrome and Type 2 Diabetes Immunopathogenesis." CPD Bulletin Clinical Biochemistry 9.2 (2024): 1-8.
Chicago
Jinger, Surendra K., Kishori L. Meena, Ghanshyam Gahlot and Prakash S. Hundekar. "The Significant Role Biomarkers of Inflammatory Cytokines & Adipokines in Patients with Metabolic syndrome and Type 2 Diabetes Immunopathogenesis." CPD Bulletin Clinical Biochemistry 9, no. 2 (2024): 1-8.
Harvard
Jinger, S. K., Meena, K. L., Gahlot, G. and Hundekar, P. S. (2024) 'The Significant Role Biomarkers of Inflammatory Cytokines & Adipokines in Patients with Metabolic syndrome and Type 2 Diabetes Immunopathogenesis' CPD Bulletin Clinical Biochemistry 9(2), pp. 1-8.
Vancouver
Jinger SK, Meena KL, Gahlot G, Hundekar PS. The Significant Role Biomarkers of Inflammatory Cytokines & Adipokines in Patients with Metabolic syndrome and Type 2 Diabetes Immunopathogenesis. CPD Bulletin Clinical Biochemistry. 2024 Dec;9(2):1-8.